Filing Details
- Accession Number:
- 0001593968-24-000563
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-08 17:30:37
- Reporting Period:
- 2024-04-04
- Accepted Time:
- 2024-04-08 17:30:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1824893 | Surrozen Inc. | SRZN | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1325818 | O Charles Williams | C/O Surrozen, Inc. 171 Oyster Point Blvd., Suite 400 South San Francisco CA 94080 | Cfo And Coo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-04-04 | 1,474 | $0.00 | 1,474 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Common Stock Warrant (right to buy) | Acquisiton | 2024-04-04 | 1,474 | $0.00 | 1,474 | $16.96 |
Common Stock | Series B Common Stock Warrant (right to buy) | Acquisiton | 2024-04-04 | 1,603 | $0.00 | 1,603 | $15.71 |
Common Stock | Series C Common Stock Warrant (right to buy) | Acquisiton | 2024-04-04 | 5,712 | $0.00 | 5,712 | $16.00 |
Common Stock | Series D Common Stock Warrant (right to buy) | Acquisiton | 2024-04-04 | 5,712 | $0.00 | 5,712 | $16.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1,474 | 2024-04-04 | 2029-04-04 | No | 4 | P | Direct |
1,603 | 2024-04-04 | No | 4 | P | Direct | |
5,712 | No | 4 | P | Direct | ||
5,712 | No | 4 | P | Direct |
Footnotes
- On April 4, 2024, the reporting person acquired shares in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement, dated as of April 1, 2024, by and among the Issuer and certain institutional investors and members of management, at a purchase price of $16.96 per share, which amount includes $1.25 for the accompanying common stock warrants.
- The warrant expires on the fifth trading day following the occurrence of the Series B Milestone Event (as defined in the Series B Common Stock Warrant). In the event the Series B Milestone Event has not occurred prior to the fifth anniversary of the issuance date of the warrant, the warrant will automatically terminate on such anniversary date.
- The warrant is exercisable for 30 days after the earlier of (i) the occurrence of the Series C Milestone Event (as defined in the Series C Common Stock Warrant) and (ii) a Fundamental Transaction (as defined in the Series C Common Stock Warrant).
- The warrant is exercisable for 30 days after the earlier of (i) the occurrence of the Series D Milestone Event (as defined in the Series D Common Stock Warrant) and (ii) a Fundamental Transaction (as defined in the Series D Common Stock Warrant).